![](/images/graphics-bg.png)
Corrigendum to “Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment”
Author
Source
Issue
Vol. 2017, Issue 2017 (31 Dec. 2017), pp.1-1, 1 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2017-08-13
Country of Publication
Egypt
No. of Pages
1
Main Subjects
Abstract EN
In the article titled “Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment” [1], there was an error in Acknowledgments, which should be corrected as follows.
American Psychological Association (APA)
Shazly, Gamal A.. 2017. Corrigendum to “Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment”. BioMed Research International،Vol. 2017, no. 2017, pp.1-1.
https://search.emarefa.net/detail/BIM-1138209
Modern Language Association (MLA)
Shazly, Gamal A.. Corrigendum to “Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment”. BioMed Research International No. 2017 (2017), pp.1-1.
https://search.emarefa.net/detail/BIM-1138209
American Medical Association (AMA)
Shazly, Gamal A.. Corrigendum to “Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment”. BioMed Research International. 2017. Vol. 2017, no. 2017, pp.1-1.
https://search.emarefa.net/detail/BIM-1138209
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1138209